These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22338417)

  • 1. Effect of anthropometric measurements and personal data parameters on benign prostatic hyperplasia and carcinoma prostate.
    Naz Z; Anjum S
    J Ayub Med Coll Abbottabad; 2010; 22(3):54-7. PubMed ID: 22338417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.
    Burke JP; Rhodes T; Jacobson DJ; McGree ME; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Jul; 164(1):41-6. PubMed ID: 16611664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
    Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
    Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China.
    Gu F
    Chin Med J (Engl); 2000 Apr; 113(4):299-302. PubMed ID: 11775222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
    Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
    Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
    Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
    Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of weight and obesity through life and risk of benign prostatic hyperplasia.
    Zucchetto A; Tavani A; Dal Maso L; Gallus S; Negri E; Talamini R; Franceschi S; Montella M; La Vecchia C
    Int J Obes (Lond); 2005 Jul; 29(7):798-803. PubMed ID: 15917855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology and natural course of benign prostatic hyperplasia].
    Blom JH; Schröder FH
    Urologe A; 1992 May; 31(3):129-34. PubMed ID: 1377429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between benign prostatic hyperplasia and obesity and estrogen].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang].
    Ning X; Shi JP; Wu ZY; Zheng LG; Wang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):276-80. PubMed ID: 12820944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
    Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
    Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
    Michalakis K; Williams CJ; Mitsiades N; Blakeman J; Balafouta-Tselenis S; Giannopoulos A; Mantzoros CS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):308-13. PubMed ID: 17301264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate.
    Shakya G; Malla S; Shakya KN
    Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.